| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 175,234 | 170,295 | 167,532 | 167,284 | | Cost of Revenue | 99,871 | 99,444 | 98,455 | 98,470 | | | Gross Profit | 75,363 | 70,851 | 69,077 | 68,814 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 49,039 | 50,972 | 49,605 | 52,855 | | Non Recurring | 8,894 |
-
|
-
|
-
| | Others | (3,053) | 4,307 | 3,563 | 5,131 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,483 | 15,572 | 15,909 | 10,828 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 97 | 121 | 166 | 416 | | Earnings Before Interest And Taxes | 20,580 | 15,693 | 16,075 | 11,102 | | Interest Expense | 1,563 | 1,606 | 1,885 | 2,051 | | Income Before Tax | 19,017 | 14,087 | 14,190 | 9,051 | | Income Tax Expense | 7,150 | 5,064 | 5,283 | 3,302 | | Minority Interest | (199) | (81) | (136) | (142) | | | | Net Income From Continuing Ops | 12,084 | 8,942 | 8,771 | 5,749 | | | Non-recurring Events | | Discontinued Operations | (87) | (423) | (52) | (395) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,581 | 8,519 | 8,719 | 5,354 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,581 | $8,519 | $8,719 | $5,354 |
|
0.83% Nasdaq 
Income Statement
